PTHS
Pelthos Therapeutics Inc.Company with tickers: PTHS
Market Cap
$99.79M
Shares Outstanding
3,475,645
CIK
1919246
CUSIP
171126204
Website
Visit website
Investor Relations
Investor relations
Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.
No Compensation Data
No Summary Compensation Table has been imported from this company's proxy statements yet.
Executive changes
| Person | Role | Change | Filed |
|---|---|---|---|
| Francis Knuettel II | Chief Financial Officer, Treasurer and Secretary | Terminated | 2026-05-21 |